Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-25-000834
Filing Date
2025-06-09
Accepted
2025-06-09 16:05:31
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 e664602_4-muehler.html 4  
1 e664602_4-muehler.xml 4 4007
  Complete submission text file 0001193805-25-000834.txt   5551
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK CITY NY 10036
Business Address
Muehler Andreas (Reporting) CIK: 0001850468 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36201 | Film No.: 251034026